Cytosorbents Corporation Company Profile (NASDAQ:CTSO)

About Cytosorbents Corporation

Cytosorbents Corporation logoCytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads that remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. The Company's CytoSorb is an extracorporeal cytokine filter and is designed to reduce the cytokine storm that causes inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury and pancreatitis. In addition, CytoSorb is used in other inflammatory conditions, such as cardiac surgery and autoimmune disease flares and cancer cachexia. It also has other products under development based upon its blood purification technology, including HemoDefend, ContrastSorb, DrugSorb, BetaSorb and others.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CTSO
  • CUSIP:
Key Metrics:
  • Previous Close: $5.60
  • 50 Day Moving Average: $5.72
  • 200 Day Moving Average: $5.54
  • 52-Week Range: $3.80 - $6.90
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -16.00
  • P/E Growth: 0.00
  • Market Cap: $142.62M
  • Outstanding Shares: 25,468,000
  • Beta: -0.07
  • Net Margins: -120.04%
  • Return on Equity: -193.13%
  • Return on Assets: -85.97%
  • Debt-to-Equity Ratio: 3.26%
  • Current Ratio: 1.81%
  • Quick Ratio: 1.60%
Additional Links:
Companies Related to Cytosorbents Corporation:

Analyst Ratings

Consensus Ratings for Cytosorbents Corporation (NASDAQ:CTSO) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.45 (175.89% upside)

Analysts' Ratings History for Cytosorbents Corporation (NASDAQ:CTSO)
DateFirmActionRatingPrice TargetDetails
1/23/2017Maxim GroupBoost Price TargetBuy$8.00 -> $10.00View Rating Details
11/14/2016B. RileyReiterated RatingBuy$11.25View Rating Details
11/8/2016HC WainwrightReiterated RatingBuyView Rating Details
10/26/2016AegisInitiated CoverageBuy$20.00View Rating Details
10/4/2016Brean CapitalInitiated CoverageBuy$24.00View Rating Details
10/29/2015WBB SecuritiesUpgradeSpeculative Buy -> Buy$13.00View Rating Details
5/12/2015MLV & Co.Lower Price TargetBuy$28.00 -> $21.00View Rating Details
(Data available from 2/28/2015 forward)


Earnings History for Cytosorbents Corporation (NASDAQ:CTSO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2016Q116($0.10)($0.08)$1.73 million$1.80 millionViewN/AView Earnings Details
3/9/2016Q415($0.08)($0.08)$1.58 millionViewN/AView Earnings Details
11/13/2015Q315($0.10)($0.11)$1.26 million$1.30 millionViewListenView Earnings Details
8/13/2015Q215($0.11)$0.05$1.69 millionViewListenView Earnings Details
5/11/2015Q115($0.13)($0.11)$724.00 millionViewListenView Earnings Details
11/13/2014($0.01)($0.01)ViewN/AView Earnings Details
8/12/2014($0.01)($0.01)ViewN/AView Earnings Details
3/31/2014($0.01)($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cytosorbents Corporation (NASDAQ:CTSO)
Current Year EPS Consensus Estimate: $-0.39 EPS
Next Year EPS Consensus Estimate: $-0.35 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.10)($0.10)($0.10)
Q2 20162($0.09)($0.09)($0.09)
Q3 20162($0.10)($0.09)($0.10)
Q4 20162($0.10)($0.08)($0.09)
(Data provided by Zacks Investment Research)


Dividend History for Cytosorbents Corporation (NASDAQ:CTSO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Cytosorbents Corporation (NASDAQ:CTSO)
Insider Ownership Percentage: 4.20%
Institutional Ownership Percentage: 6.07%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/9/2016Phillip P. ChanInsiderBuy4,600$5.40$24,840.00View SEC Filing  
12/6/2016Kathleen P BlochCFOBuy1,000$4.83$4,830.00View SEC Filing  
8/24/2016Phillip P ChanInsiderBuy5,000$4.89$24,450.00View SEC Filing  
6/7/2016Michael G BatorDirectorBuy3,000$4.88$14,640.00View SEC Filing  
10/29/2015Vincent CapponiCOOSell4,000$7.50$30,000.00View SEC Filing  
10/15/2015Al KrausDirectorSell6,774$6.22$42,134.28View SEC Filing  
10/8/2015Al KrausDirectorSell10,000$6.39$63,900.00View SEC Filing  
10/1/2015Al KrausDirectorSell10,000$6.26$62,600.00View SEC Filing  
9/24/2015Al KrausDirectorSell10,000$6.44$64,400.00View SEC Filing  
9/17/2015Al KrausDirectorSell10,000$6.64$66,400.00View SEC Filing  
9/10/2015Al KrausDirectorSell10,000$7.26$72,600.00View SEC Filing  
9/3/2015Al KrausDirectorSell10,000$7.26$72,600.00View SEC Filing  
8/27/2015Al KrausDirectorSell10,000$6.39$63,900.00View SEC Filing  
8/20/2015Al KrausDirectorSell10,000$7.26$72,600.00View SEC Filing  
8/13/2015Al KrausDirectorSell10,000$6.26$62,600.00View SEC Filing  
7/23/2015Al KrausDirectorSell10,000$6.28$62,800.00View SEC Filing  
7/16/2015Al KrausDirectorSell10,000$6.33$63,300.00View SEC Filing  
7/9/2015Al KrausDirectorSell10,000$5.98$59,800.00View SEC Filing  
7/2/2015Al KrausDirectorSell10,000$6.29$62,900.00View SEC Filing  
6/25/2015Al KrausDirectorSell13,205$7.33$96,792.65View SEC Filing  
6/18/2015Al KrausDirectorSell10,000$5.78$57,800.00View SEC Filing  
6/11/2015Al KrausDirectorSell10,000$6.29$62,900.00View SEC Filing  
6/4/2015Al KrausDirectorSell10,000$6.30$63,000.00View SEC Filing  
5/28/2015Al KrausDirectorSell10,000$6.32$63,200.00View SEC Filing  
11/17/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
11/10/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
11/3/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
10/27/2014Al KrausDirectorSell100,000$0.24$24,000.00View SEC Filing  
10/10/2014James T GuntonDirectorSell1,240,762$0.24$297,782.88View SEC Filing  
10/6/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
9/29/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
9/25/2014Al KrausDirectorSell41,500$0.23$9,545.00View SEC Filing  
9/22/2014Al KrausDirectorSell8,500$0.23$1,955.00View SEC Filing  
9/15/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
9/12/2014James T GuntonDirectorSell30,450$0.24$7,308.00View SEC Filing  
9/8/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
9/5/2014James T GuntonDirectorSell100,000$0.24$24,000.00View SEC Filing  
9/2/2014Al KrausDirectorSell50,000$0.25$12,500.00View SEC Filing  
9/2/2014Kathleen P BlochCFOBuy65,000$0.23$14,950.00View SEC Filing  
8/28/2014James T GuntonDirectorSell214,387$0.24$51,452.88View SEC Filing  
8/27/2014James T GuntonDirectorSell1,360,000$0.24$326,400.00View SEC Filing  
8/25/2014Al KrausDirectorSell100,000$0.25$25,000.00View SEC Filing  
8/18/2014Al KrausDirectorSell100,000$0.27$27,000.00View SEC Filing  
8/11/2014Al KrausDirectorSell100,000$0.28$28,000.00View SEC Filing  
8/4/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  
7/21/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  
7/10/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  
7/7/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  
6/23/2014Al KrausDirectorSell50,000$0.23$11,500.00View SEC Filing  
6/18/2014Al KrausDirectorSell50,000$0.24$12,000.00View SEC Filing  
5/20/2014Kathleen P BlochCFOBuy110,000$0.24$26,400.00View SEC Filing  
9/4/2012Phillip P ChanCEOBuy190,000$0.13$24,700.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Cytosorbents Corporation (NASDAQ:CTSO)
DateHeadline logoCytoSorbents to Report Fiscal 2016 Operating and Financial Results (NASDAQ:CTSO) - February 24 at 12:05 PM
News IconTarget Price Review & Stock Update on Cytosorbents Corporation (NASDAQ:CTSO) - Rockville Register (NASDAQ:CTSO) - February 17 at 8:23 AM logoCytosorbents Corporation (NASDAQ:CTSO) EPS Projection At $-0.085 - (NASDAQ:CTSO) - February 16 at 1:28 PM
News IconAre Analysts Forecasting a Near-Term Upswing For Cytosorbents Corporation (NASDAQ:CTSO)? - Winfield Review (NASDAQ:CTSO) - February 16 at 1:28 PM
News IconEquity in Focus: Cytosorbents Corporation (CTSO) - Providence Standard (NASDAQ:CTSO) - February 9 at 3:02 AM logoCytosorbents Corporation (NASDAQ:CTSO) Is Expected To Post EPS Of $-0.085 - (NASDAQ:CTSO) - February 9 at 3:02 AM logoCytoSorbents to Present at the 2nd Annual Disruptive Growth & Healthcare Conference (NASDAQ:CTSO) - February 8 at 4:59 PM logoCytoSorbents to Present at the 19th Annual BIO CEO & Investor Conference - PR Newswire (press release) (NASDAQ:CTSO) - February 7 at 5:41 PM
News IconA look at Cytosorbents Corporation (NASDAQ:CTSO)'s track record of earnings - Post Analyst (NASDAQ:CTSO) - February 7 at 5:41 PM logoCytoSorbents to Present at the 19th Annual BIO CEO & Investor Conference (NASDAQ:CTSO) - February 7 at 5:41 PM
News IconTrading Watch: FCF and Piotroski Score Check for Cytosorbents Corporation (NASDAQ:CTSO) - The Tribune (NASDAQ:CTSO) - February 1 at 9:58 PM
News IconSteering Attention Towards Earnings; Analysts Weigh in on Cytosorbents Corporation (NASDAQ:CTSO) Stock - Aiken Advocate (NASDAQ:CTSO) - January 30 at 5:29 PM
News IconLooking at the Gauges on Cytosorbents Corporation (CTSO) - Sherwood Daily (NASDAQ:CTSO) - January 27 at 6:05 PM
News IconEarnings in Full Force, Analysts Take Aim at Cytosorbents Corporation (NASDAQ:CTSO) - Wall Street Beacon (NASDAQ:CTSO) - January 26 at 10:48 PM
News IconRSI Review on Shares of Cytosorbents Corporation (CTSO) - Sherwood Daily (NASDAQ:CTSO) - January 26 at 5:45 PM
News IconCytosorbents Corporation (NASDAQ:CTSO) Quarterly EPS Projection At $-0.1 - Stock Observer (NASDAQ:CTSO) - January 26 at 5:45 PM
News IconConsensus Estimates on Earnings & Stock Price in Focus for Cytosorbents Corporation (NASDAQ:CTSO) Shares - Aiken Advocate (NASDAQ:CTSO) - January 24 at 10:12 PM logoCytoSorbents Launches VetResQ™ for U.S. Veterinary Market (NASDAQ:CTSO) - January 20 at 5:47 PM logoCytoSorbents Launches VetResQ™ for U.S. Veterinary Market (NASDAQ:CTSO) - January 20 at 5:47 PM
News IconWhat are Brokerage Firms Saying About Cytosorbents Corporation (NASDAQ:CTSO)? - Aiken Advocate (NASDAQ:CTSO) - January 17 at 8:38 AM logoCTSO: Poised For Strong 2017. Fresenius Deal A Win-Win-Win (NASDAQ:CTSO) - January 16 at 4:34 PM
News IconCytoSorbents Corp CTSO Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:CTSO) - January 14 at 3:19 AM
News IconWill The Needle Move For Cytosorbents Corporation (NASDAQ:CTSO) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:CTSO) - January 13 at 10:19 PM logoCytoSorbents Pre-announces Q4 2016 and Full-Year 2016 Results - Yahoo Finance (NASDAQ:CTSO) - January 12 at 3:04 AM
News IconEPS Of Cytosorbents Corporation (NASDAQ:CTSO) At $-0.1 - Stock Observer (NASDAQ:CTSO) - January 12 at 3:04 AM
News IconStock Reaching Most Volatile List Today: Cytosorbents Corporation (NASDAQ:CTSO) - Wall Street Beacon (NASDAQ:CTSO) - January 12 at 3:04 AM
News IconCytosorbents Corp. (NASDAQ: CTSO) Expected to Announce Doubling in Sales for 2016 (NASDAQ:CTSO) - January 11 at 10:03 PM
News IconNews Impact Score Of Cytosorbents Corporation (NASDAQ:CTSO) Set At 0 - Stock Observer (NASDAQ:CTSO) - January 11 at 5:01 PM logoCytosorbents Corporation (NASDAQ:CTSO) EPS Estimate At $-0.085 - (NASDAQ:CTSO) - January 11 at 5:01 PM logoCYTOSORBENTS CORPORATION (NASDAQ:CTSO) Files An 8-K Other Events - Market Exclusive (NASDAQ:CTSO) - January 11 at 5:01 PM
News IconCytoSorbents shares lift on Q4 prelims (NASDAQ:CTSO) - January 10 at 5:29 PM logoCytoSorbents Pre-announces Q4 2016 and Full-Year 2016 Results (NASDAQ:CTSO) - January 10 at 5:29 PM logoCYTOSORBENTS CORP Files SEC form 8-K, Other Events (NASDAQ:CTSO) - January 10 at 5:29 PM
News IconFresenius expands CytoSorbents deal (NASDAQ:CTSO) - January 9 at 4:21 PM logoFresenius Medical Care and CytoSorbents Expand Original Partnership and Add New Co-Marketing Agreement for Worldwide CytoSorb® Markets (NASDAQ:CTSO) - January 9 at 4:21 PM logo8:22 am CytoSorbents and Fresenius Medical Care to broaden the terms of their existing partnership; extends FMC's exclusive distributorship of CytoSorb for critical care applications in France, Poland, Sweden, Denmark, Finland, and Norway t (NASDAQ:CTSO) - January 9 at 4:21 PM logoETFs with exposure to CytoSorbents Corp. : January 9, 2017 (NASDAQ:CTSO) - January 9 at 4:21 PM logoCytosorbents Corporation (NASDAQ:CTSO) EPS Projection At $-0.1? - Stocks Daily (NASDAQ:CTSO) - January 5 at 10:16 PM logoCytoSorbents To Provide Corporate Update at Biotech Showcase ... - PR Newswire (press release) (NASDAQ:CTSO) - January 3 at 6:17 PM logoCytoSorbents To Provide Corporate Update at Biotech Showcase 2017 (NASDAQ:CTSO) - January 3 at 12:42 PM
News IconCytosorbents Corporation (NASDAQ:CTSO) EPS At $-0.1 | Stock ... - Stock Observer (NASDAQ:CTSO) - December 30 at 4:59 PM logoCTSO: Progress Towards Adoption, Reimbursement and Standard-of-Care (NASDAQ:CTSO) - December 28 at 12:02 PM
News IconTop Stock With Upside & Growth Potential: Cytosorbents Corporation (NASDAQ:CTSO) - Prospect Journal (NASDAQ:CTSO) - December 27 at 12:06 PM logoCytosorbents (CTSO) Announces Launch and Initial Sales of New CytoSor - (NASDAQ:CTSO) - December 22 at 4:43 PM logoCytosorbents (CTSO) Announces Launch and Initial Sales of New CytoSor (NASDAQ:CTSO) - December 20 at 5:17 PM logoETFs with exposure to CytoSorbents Corp. : December 19, 2016 (NASDAQ:CTSO) - December 20 at 9:40 AM logoCytoSorbents Announces First Sales of New CytoSorb® CPB Procedure Pack for Cardiac Surgery (NASDAQ:CTSO) - December 20 at 9:40 AM
News IconChart Indicators in Focus for Cytosorbents Corporation (CTSO) - Yankee Analysts (NASDAQ:CTSO) - December 18 at 4:36 PM
News IconWatching Stock Levels for Cytosorbents Corporation (NASDAQ:CTSO) - Business Daily Leader (NASDAQ:CTSO) - December 18 at 4:36 PM
News IconROIC Focus on Shares of Cytosorbents Corporation (NASDAQ:CTSO) - OIB News (NASDAQ:CTSO) - December 16 at 10:02 PM


What is Cytosorbents Corporation's stock symbol?

Cytosorbents Corporation trades on the NASDAQ under the ticker symbol "CTSO."

Where is Cytosorbents Corporation's stock going? Where will Cytosorbents Corporation's stock price be in 2017?

5 equities research analysts have issued 1-year price targets for Cytosorbents Corporation's stock. Their predictions range from $10.00 to $24.00. On average, they expect Cytosorbents Corporation's stock price to reach $15.45 in the next twelve months.

When will Cytosorbents Corporation announce their earnings?

Cytosorbents Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, March, 7th 2017.

Who owns Cytosorbents Corporation stock?

Cytosorbents Corporation's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Ladenburg Thalmann Financial Services Inc. (0.17%) and Fortaleza Asset Management Inc. (0.10%). Company insiders that own Cytosorbents Corporation stock include Al Kraus, Kathleen P Bloch, Michael G Bator, Phillip P Chan and Vincent Capponi.

Who sold Cytosorbents Corporation stock? Who is selling Cytosorbents Corporation stock?

Cytosorbents Corporation's stock was sold by a variety of institutional investors in the last quarter, including Fortaleza Asset Management Inc. and Ladenburg Thalmann Financial Services Inc..

How do I buy Cytosorbents Corporation stock?

Shares of Cytosorbents Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cytosorbents Corporation stock cost?

One share of Cytosorbents Corporation stock can currently be purchased for approximately $5.60.

Cytosorbents Corporation (NASDAQ:CTSO) Chart for Tuesday, February, 28, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Cytosorbents Corporation (NASDAQ:CTSO)

Earnings History Chart

Earnings by Quarter for Cytosorbents Corporation (NASDAQ:CTSO)

Dividend History Chart

Dividend Payments by Quarter for Cytosorbents Corporation (NASDAQ:CTSO)

Last Updated on 2/28/2017 by Staff